{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:24:38Z","timestamp":1793597078601,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:00:00Z","timestamp":1559088000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:00:00Z","timestamp":1559088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00392-019-01493-z","type":"journal-article","created":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T20:26:13Z","timestamp":1559161573000},"page":"96-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices"],"prefix":"10.1007","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6357-5213","authenticated-orcid":false,"given":"Daniele","family":"Pastori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Miyazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orsolya","family":"Sz\u00e9kely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhan","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Farcomeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,29]]},"reference":[{"issue":"9","key":"1493_CR1","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1093\/europace\/eux163","volume":"19","author":"BC Gorenek","year":"2017","unstructured":"Gorenek BC, Bax J, Boriani G, Chen SA, Dagres N, Glotzer TV, Healey JS, Israel CW, Kudaiberdieva G, Levin LA, Lip GYH, Martin D, Okumura K, Svendsen JH, Tse HF, Botto GLC-C, Group ESCSD (2017) Device-detected subclinical atrial tachyarrhythmias: definition, implications and management\u2014an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). Europace Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol 19(9):1556\u20131578. \nhttps:\/\/doi.org\/10.1093\/europace\/eux163","journal-title":"Europace Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol"},{"issue":"3","key":"1493_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/14779072.2018.1438267","volume":"16","author":"A Di Cori","year":"2018","unstructured":"Di Cori A, Lilli A, Zucchelli G, Zaca V (2018) Role of cardiac electronic implantable device in the stratification and management of embolic risk of silent atrial fibrillation: are all atrial fibrillations created equal? Expert Rev Cardiovasc Ther 16(3):175\u2013181. \nhttps:\/\/doi.org\/10.1080\/14779072.2018.1438267","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"4\u20135","key":"1493_CR3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.pcad.2017.12.002","volume":"60","author":"K Miyazawa","year":"2018","unstructured":"Miyazawa K, Pastori D, Lip GYH (2018) Quantifying time in atrial fibrillation and the need for anticoagulation. Prog Cardiovasc Dis 60(4\u20135):537\u2013541. \nhttps:\/\/doi.org\/10.1016\/j.pcad.2017.12.002","journal-title":"Prog Cardiovasc Dis"},{"issue":"2","key":"1493_CR4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1105575","volume":"366","author":"JS Healey","year":"2012","unstructured":"Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH, Investigators A (2012) Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 366(2):120\u2013129. \nhttps:\/\/doi.org\/10.1056\/NEJMoa1105575","journal-title":"N Engl J Med"},{"issue":"12","key":"1493_CR5","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrcardio.2017.94","volume":"14","author":"B Freedman","year":"2017","unstructured":"Freedman B, Boriani G, Glotzer TV, Healey JS, Kirchhof P, Potpara TS (2017) Management of atrial high-rate episodes detected by cardiac implanted electronic devices. Nat Rev Cardiol 14(12):701\u2013714. \nhttps:\/\/doi.org\/10.1038\/nrcardio.2017.94","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"1493_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/europace\/euw279","volume":"19","author":"AJ Camm","year":"2017","unstructured":"Camm AJ, Simantirakis E, Goette A, Lip GY, Vardas P, Calvert M, Chlouverakis G, Diener HC, Kirchhof P (2017) Atrial high-rate episodes and stroke prevention. Europace Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol 19(2):169\u2013179. \nhttps:\/\/doi.org\/10.1093\/europace\/euw279","journal-title":"Europace Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol"},{"issue":"8","key":"1493_CR7","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/eurheartj\/eht491","volume":"35","author":"G Boriani","year":"2014","unstructured":"Boriani G, Glotzer TV, Santini M, West TM, De Melis M, Sepsi M, Gasparini M, Lewalter T, Camm JA, Singer DE (2014) Device-detected atrial fibrillation and risk for stroke: an analysis of %3e10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices). Eur Heart J 35(8):508\u2013516. \nhttps:\/\/doi.org\/10.1093\/eurheartj\/eht491","journal-title":"Eur Heart J"},{"key":"1493_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-019-01432-y","author":"K Miyazawa","year":"2019","unstructured":"Miyazawa K, Pastori D, Li YG, Szekely O, Shahid F, Boriani G, Lip GYH (2019) Atrial high rate episodes in patients with cardiac implantable electronic devices: implications for clinical outcomes. Clin Res Cardiol. \nhttps:\/\/doi.org\/10.1007\/s00392-019-01432-y","journal-title":"Clin Res Cardiol"},{"issue":"26","key":"1493_CR9","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1093\/eurheartj\/ehv115","volume":"36","author":"DT Martin","year":"2015","unstructured":"Martin DT, Bersohn MM, Waldo AL, Wathen MS, Choucair WK, Lip GY, Ip J, Holcomb R, Akar JG, Halperin JL, Investigators I (2015) Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. Eur Heart J 36(26):1660\u20131668. \nhttps:\/\/doi.org\/10.1093\/eurheartj\/ehv115","journal-title":"Eur Heart J"},{"key":"1493_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw210","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P, Authors\/Task Force M, Document R (2016) 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS: the Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC endorsed by the European Stroke Organisation (ESO). Eur Heart J. \nhttps:\/\/doi.org\/10.1093\/eurheartj\/ehw210","journal-title":"Eur Heart J"},{"issue":"1","key":"1493_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1001\/jamainternmed.2013.11912","volume":"174","author":"EZ Soliman","year":"2014","unstructured":"Soliman EZ, Safford MM, Muntner P, Khodneva Y, Dawood FZ, Zakai NA, Thacker EL, Judd S, Howard VJ, Howard G, Herrington DM, Cushman M (2014) Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med 174(1):107\u2013114. \nhttps:\/\/doi.org\/10.1001\/jamainternmed.2013.11912","journal-title":"JAMA Intern Med"},{"issue":"6","key":"1493_CR12","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.14-2414","volume":"147","author":"D Pastori","year":"2015","unstructured":"Pastori D, Pignatelli P, Angelico F, Farcomeni A, Del Ben M, Vicario T, Bucci T, Raparelli V, Cangemi R, Tanzilli G, Lip GY, Violi F (2015) Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors. Chest 147(6):1644\u20131650. \nhttps:\/\/doi.org\/10.1378\/chest.14-2414","journal-title":"Chest"},{"issue":"9","key":"1493_CR13","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/s00392-018-1244-0","volume":"107","author":"D Pastori","year":"2018","unstructured":"Pastori D, Miyazawa K, Li Y, Shahid F, Hado H, Lip GYH (2018) Inflammation and the risk of atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices. Clinical Res Cardiol 107(9):772\u2013777. \nhttps:\/\/doi.org\/10.1007\/s00392-018-1244-0","journal-title":"Clinical Res Cardiol"},{"issue":"2","key":"1493_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1080\/14017431.2016.1260768","volume":"51","author":"J Jacobsson","year":"2017","unstructured":"Jacobsson J, Platonov PG, Reitan C, Carlsson J, Borgquist R (2017) Atrial high-rate episodes predict clinical outcome in patients with cardiac resynchronization therapy. Scand Cardiovasc J 51(2):74\u201381. \nhttps:\/\/doi.org\/10.1080\/14017431.2016.1260768","journal-title":"Scand Cardiovasc J"},{"issue":"4","key":"1493_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1161\/CIRCULATIONAHA.114.015134","volume":"132","author":"T Shibata","year":"2015","unstructured":"Shibata T, Kawakami S, Noguchi T, Tanaka T, Asaumi Y, Kanaya T, Nagai T, Nakao K, Fujino M, Nagatsuka K, Ishibashi-Ueda H, Nishimura K, Miyamoto Y, Kusano K, Anzai T, Goto Y, Ogawa H, Yasuda S (2015) Prevalence, clinical features, and prognosis of acute myocardial infarction attributable to coronary artery embolism. Circulation 132(4):241\u2013250. \nhttps:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.015134","journal-title":"Circulation"},{"key":"1493_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003347","author":"F Violi","year":"2016","unstructured":"Violi F, Soliman EZ, Pignatelli P, Pastori D (2016) Atrial fibrillation and myocardial infarction: a systematic review and appraisal of pathophysiologic mechanisms. J Am Heart Assoc. \nhttps:\/\/doi.org\/10.1161\/JAHA.116.003347","journal-title":"J Am Heart Assoc"},{"key":"1493_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ahj.2017.04.015","volume":"190","author":"P Kirchhof","year":"2017","unstructured":"Kirchhof P, Blank BF, Calvert M, Camm AJ, Chlouverakis G, Diener HC, Goette A, Huening A, Lip GYH, Simantirakis E, Vardas P (2017) Probing oral anticoagulation in patients with atrial high rate episodes: rationale and design of the non-vitamin K antagonist oral anticoagulants in patients with atrial high rate episodes (NOAH-AFNET 6) trial. Am Heart J 190:12\u201318. \nhttps:\/\/doi.org\/10.1016\/j.ahj.2017.04.015","journal-title":"Am Heart J"},{"issue":"1","key":"1493_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jacc.2018.04.036","volume":"72","author":"CJ Lee","year":"2018","unstructured":"Lee CJ, Gerds TA, Carlson N, Bonde AN, Gislason GH, Lamberts M, Olesen JB, Pallisgaard JL, Hansen ML, Torp-Pedersen C (2018) Risk of myocardial infarction in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol 72(1):17\u201326. \nhttps:\/\/doi.org\/10.1016\/j.jacc.2018.04.036","journal-title":"J Am Coll Cardiol"},{"key":"1493_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-019-01416-y","author":"T Schupp","year":"2019","unstructured":"Schupp T, Akin I, Reiser L, Bollow A, Taton G, Reichelt T, Ellguth D, Engelke N, Ansari U, Mashayekhi K, Weiss C, Nienaber C, Akin M, Borggrefe M, Behnes M (2019) Prognostic impact of recurrences of ventricular tachyarrhythmias and appropriate ICD therapies in a high-risk ICD population. Clin Res Cardiol. \nhttps:\/\/doi.org\/10.1007\/s00392-019-01416-y","journal-title":"Clin Res Cardiol"},{"key":"1493_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-018-1258-z","author":"G De Vincentis","year":"2018","unstructured":"De Vincentis G, Frantellizzi V, Fedele F, Farcomeni A, Scarparo P, Salvi N, Fegatelli DA, Mancone M, Verschure DO, Verberne HJ (2018) Role of cardiac (123)I-mIBG imaging in predicting arrhythmic events in stable chronic heart failure patients with an ICD. J Nucl Cardiol. \nhttps:\/\/doi.org\/10.1007\/s12350-018-1258-z","journal-title":"J Nucl Cardiol"},{"key":"1493_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-019-01440-y","author":"P Martens","year":"2019","unstructured":"Martens P, Nuyens D, Rivero-Ayerza M, Van Herendael H, Vercammen J, Ceyssens W, Luwel E, Dupont M, Mullens W (2019) Sacubitril\/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction. Clin Res Cardiol. \nhttps:\/\/doi.org\/10.1007\/s00392-019-01440-y","journal-title":"Clin Res Cardiol"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-019-01493-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-019-01493-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-019-01493-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T23:12:27Z","timestamp":1590621147000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-019-01493-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,29]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["1493"],"URL":"https:\/\/doi.org\/10.1007\/s00392-019-01493-z","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,29]]},"assertion":[{"value":"3 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None related to this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}